Search

everythinglearnresearchcommunity

for

Search:↓

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Digital health technology improves health and medication adherence in kidney transplant patients.

A kidney transplant and immunosuppressive treatment stopped the skin disease in a patient.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Feminizing hormone therapy increases kidney filtration rate.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Patients with chronic kidney disease on hemodialysis often have skin problems.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

Patients on hemodialysis commonly have skin color changes, nail problems, dry skin, and itching.

Almost all kidney transplant patients had complications from immunosuppressive therapy, with excessive hair growth being the most common.

Most end-stage renal disease patients in Jordan have skin issues like dryness and itching.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Some CKD patients' kidney function remains stable over time.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Skin problems are very common in people with end-stage kidney disease.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

A benign skin tumor grew quickly in a dialysis patient and was surgically removed.